Patent applications published 22 December 2010
Selected patent applications from the weekly European Patents Bulletin
- Oxadiazoanthracene compounds for the treatment of diabetes
TransTech Pharma 2262364*
- Use of ‘-thio-2’-deoxynucleosides as ANRI orthopoxvirus agents
Southern Research Institute 2262365*
- Compounds and methods for treating oestrogen receptor related diseases
Shenogen Pharma Group 2262366*
- Oral pharmaceutical compsns of buprenorphone and method of use
Theraquest Biosciences 2262367*
- Dicyclanil formulation
Novartis 2262368*
- Lipid-oil-water nanoemulsion delivery system for microtubule-interacting agents
Shorr, Robert; Rodriguez, Robert 2262369*
- Di-fluoro containing compounds as cysteine protease inhibitors
Virobay 2262370*
- LPA receptor agonists and antagonists
Rxbio 2262371*
- Non-aqueous generation of chlorine dioxide
Diversey 2262372*
- Methods and compsns for wound healing
Mcanulty, Jonathan; Murphy, Christopher; Abbott, Nicholas 2262474*
- Chewable tablet and method of formulating
Schering-Plough Healthcare Products 2262475*
- Drug delivery to the anterior and posterior segments of the eye using eye drops
Rekik, Raouf 2262476*
- Process for preparing concentrated aqueous micellar solutions
F Hoffmann-La Roche 2262477*
- Activated nitric oxide donors and methods of making and using thereof
University of Utah Research Foundation 2262478*
- Amorphous arformoterol L-(+)-tartrate
Actavis Group 2262479*
- Immunomodulator particles and methods of treating
Liquidia Technologies 2262480*
- Bupivacaine formulation in a polyorthoester carrier
Medtronic 2262481*
- Controlled release drug delivery systems and pharmaceutical compsns formed therewith
Lubrizol Advanced Materials 2262482*
- Modified release pharmaceutical compsns comprising mycophenolate and processes thereof
Panacea Biotec 2262483*
- Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic
Depomed 2262484*
- Modified release compsn comprising doxofylline
Eurodrug Laboratories 2262485*
- Quetiapine compsn
KRKA 2262486*
- An orally disintegrating tablet of cilostazol
Otsuka Pharmaceutical 2262487*
- Colchicine solid complex: methods of making; and methods of use thereof
Mutual Pharmaceutical 2262488*
- Hollow nanoparticles and uses thereof
Deutsches Krebsforschungszentrum 2262489*
- Transdermal therapeutic system having stabilised membrane
LTS Lohmann Therapie-Systeme 2262490*
- Therapy for disorders of the proximal digestive tract
Ore Pharmaceuticals 2262491*
- Methods of treating hyperacidic disorders
Amgen; Yale University 2262492*
- Methods of treatment employing prolonged continuous infusion of belinostat
Topotarget 2262493*
- Inhibition of post-radiation tumour growth by an inhibitor of vasculogenesis
The Board of Trustees of the Leland Stanford Junior University 2262494*
- Pharmaceutical compsn comprising racetam and carnitine and process for its preparation
Biolab Sanus Farmacéutica 2262495*
- Compounds and compsns as modulators of GPR119 activity
IRM LLC 2262496*
- S1P3 receptor inhibitors for treating inflammation
Allergan 2262497*
- Pyrimidines and pyridines useful as inhibitors of protein kinases
Vertex Pharmaceuticals 2262498*
- Method of treating cancer using a neuropeptide Y5R (NP Y5R) antagonist
University Health Network 2262499*
- Thienopyridone derivatives as AMP-activated protein kinase (AMPK) activators
Merck Patent 2262500*
- Treatment of sepsis and 5-ethyl-1-phenyl-2(1H)-pyridone and novel methods for synthesis
Solanon 2262501*
- Compsns and methods for alleviating depression or improving cognition
Clera 2262502*
- Formulations with sanguinarine, chelerythine or chelidonine for the treatment of warts, verrucas and psoriatic plaques
Indena 2262503*
- Combination therapy 238
AstraZeneca 2262504*
- Substituted heterocycle fused gamma-carbolines solid
Intra-Cellular Therapies 2262505*
- Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection
Alcon Research 2262506*
- Methods of increasing epidermal skin thickness by topical administration of a 19-NOR containing vitamin D compound
Wisconsin Alumni Research Foundation 2262507*
- Substituted-p-quinone derivatives for treatment of oxidative stress diseases
Edison Pharmaceuticals 2262508*
- Gallium compounds and methods of use to treat inflammatory bowel disease
Bernstein, Lawrence 2262509*
- Wound treatment system and method
Pulse Medical Technologies 2262510*
- Method for inducing the differentiation of blood moncytes into functional dendritic cells
Yale University 2262511*
- Compsns and methods for using stromal cells to enhance treatment of central nervous system injuries
Henry Ford Health System 2262512*
- Use of mesenchymal stem cells for treating genetic diseases and disorders
Osiris Therapeutics 2262513*
- Agents for promoting secretion and/or suppressing decrease of adiponectin
Snow Brand Milk Products; Bongrain 2262514*
- Use of black soybean for treating ophthalmic diseases
Liu, Wan-Tzu Liao 2262515*
- Compsn containing capsicum for treating a skin disorder
Rezai-Fard, Ali 2262516*
- Method of medicinal tobacco oil production
Murzagaliyev, Abat 2262517*
- Extract of oil palm leaves comprising phenolic acids
Nova Laboratories 2262518*